Please login to the form below

Not currently logged in

Excellence in Innovation

Sponsored by

Back to Results


Merck Growth Hormone eHealth Programme

by Merck
with support from W2O Group

Summary of work

Children with growth hormone deficiency follow a difficult, prolonged and complex administration treatment regimen. Key to optimal outcomes is the maintenance of high adherence. Over the past 10 years, Merck has launched a programme of eHealth technologies, each of which can stand alone but which together have created a unique eHealth ecosystem to improve treatment adherence, quality of life and growth response. How does it help patients? A fun smartphone game for kids teaches them about their disease and treatment. A device was also developed that improves patient convenience and comfort, with relatively simple injections. What’s in it for HCPs? This device automatically records the time and dose of each injection and sends the treating physicians real-time adherence data, giving them confidence that treatment is being taken as prescribed and allowing them to respond quickly if it’s not. What about the parents? A parent-focused smartphone app allows parents to monitor the device data from their phone, giving them peace of mind. Does it really work? There is evidence that this is having a real impact. ECOS, the first multinational observational study with long-term follow-up on the use of an eHealth platform, demonstrated high treatment adherence and relevant growth response.

Judges' comments

Merck’s project was truly innovative. The Easy Pod technology is a fantastic example of triage between patient, carer and healthcare professional, particularly engaging the children/teenagers in an impressive way. They have remarkable adherence rates generated from both the device and study.

Highly commended

Video Journal of Hematological Oncology (VJHemOnc) - by Magdalen Medical Publishing
with support from Brandcast Health


Bayer iMCM Lighthouse Project - by Bayer
with support from Oi Ltd

‘Make The Connection’ – Helping Paediatricians Join the Dots to Recognise MPS I - by Sanofi Genzyme
with support from Health IQ, Republic M! and Havas Life Medicom

Key dates

Entry deadline 26 August 2021
Extended entry deadline 2 September 2021*
*additional fee applies
Judging Day 1 October 2021
Company of the Year Interviews 22 October 2021
PMEA Event 24 November 2021